亞大基因科技股份有限公司
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
1. Next Generation Sequencing (NGS) testing providers scale clinical diagnostics portfolio globally
2. Clinical researchers accelerate large-scale multi-comics data processing
3. Bioinformatics developers release new analysis software products at record-b
2. Clinical researchers accelerate large-scale multi-comics data processing
3. Bioinformatics developers release new analysis software products at record-b
Founded Year
2015
Unified Business No.
24952648
Status
Active
Number of Employees
0
Total Paid-in
Capital
101,635,035 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
We want to help you operationalize biomedical data, analytics, and machine learning to deliver on the promise of precision medicine.
As a data and machine learning (ML) company, we envision the cloud technology that will transform healthcare in routin
As a data and machine learning (ML) company, we envision the cloud technology that will transform healthcare in routin
